Jonathan D. Buhrman, Ph.D.

2012 Immunology University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
"Jonathan Buhrman"


Sign in to add mentor
Jill E. Slansky grad student 2012 University of Colorado, Denver
 (Optimizing mimotope identification and vaccine strategies to improve T cell responses against tumor antigens.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Waugh KA, Leach SM, Moore BL, et al. (2016) Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model. Journal of Immunology (Baltimore, Md. : 1950)
Buhrman JD, Jordan KR, Munson DJ, et al. (2013) Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor. The Journal of Biological Chemistry. 288: 33213-25
Buhrman JD, Slansky JE. (2013) Mimotope vaccine efficacy gets a "boost" from native tumor antigens. Oncoimmunology. 2: e23492
Buhrman JD, Jordan KR, U'ren L, et al. (2013) Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens. Cancer Research. 73: 74-85
Buhrman JD, Slansky JE. (2013) Improving T cell responses to modified peptides in tumor vaccines. Immunologic Research. 55: 34-47
Jordan KR, Buhrman JD, Sprague J, et al. (2012) TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines. Cancer Immunology, Immunotherapy : Cii. 61: 1627-38
Dillon SM, Rogers LM, Howe R, et al. (2010) Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation. Journal of Immunology (Baltimore, Md. : 1950). 184: 6612-21
See more...